SCHEMBL8989100

SCHEMBL8989100

FC(F)(F)c1ccc(-c2nccc(CBr)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 19/20 0.58
SIRT2 Q8IXJ6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL894080 0.84 TRPV3 (0.58) TRPV3
SCHEMBL893694 0.84 TRPV3 (0.65) TRPV3
SCHEMBL12615472 0.80 TRPV3 (0.68) TRPV3
SCHEMBL12615426 0.79 TRPV3 (0.67) TRPV3
SCHEMBL28267570 0.78 MEN1 (0.54) TRPV3
SCHEMBL12615400 0.76 TRPV3 (0.69) TRPV3
SCHEMBL18002987 0.75 TRPV3 (0.53) TRPV3
SCHEMBL8030882 0.75 TRPV3 (0.51) TRPV3
SCHEMBL5250133 0.75 S1PR1 (0.55) TRPV3
SCHEMBL2666272 0.75 TRPV3 (0.51) TRPV3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed